Back to SNY
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line
View Full LandscapeDrug Information
Target Indication
Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line
Clinical Trial
NCT00047840Last updated: 12/16/2025
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts